Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Director departure
CC transcript
ALBIREO PHARMA, INC. (ALBO) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/14/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/08/2023 SC 13G/A BlackRock Inc. reports a 2.4% stake in ALBIREO PHARMA, INC.
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/02/2023 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Article 6:",
"SECOND AMENDED AND RESTATED BYLAWS OF ALBIREO PHARMA, INC. Article 1: Corporate Offices Section 1.1 Offices . In addition to the corporation’ s registered office set forth in the certificate of incorporation, the Board of Directors may at any time establish other offices at any place or places where the corporation is qualified to do business. Article 2: Meetings of Stockholders Section 2.1 Place of Meetings . Meetings of stockholders may be held at any place, either within or without the state of Delaware, as may be designated by the Board of Directors. The Board of Directors may, in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section 211 of the Delaware Gener..."
03/02/2023 SC 13G ICS OPPORTUNITIES, LTD. reports a 4.8% stake in ALBIREO PHARMA, INC.
03/02/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/02/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
02/27/2023 SC 13G Beryl Capital Management LLC reports a 7.1% stake in Albireo Pharma, Inc.
02/24/2023 SC 13G CARLSON CAPITAL L P reports a 5.2% stake in Albireo Pharma, Inc.
02/22/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
02/22/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 2% stake in Albireo Pharma, Inc.
02/14/2023 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 8.5% stake in Albireo Pharma, Inc.
02/14/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy